Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3030
-0.0023 (-0.75%)
At close: May 16, 2025, 4:00 PM
0.3143
+0.0113 (3.73%)
After-hours: May 16, 2025, 7:55 PM EDT
Ovid Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 21.14 | 26.3 | 27.04 | 44.87 | 187.8 | 72.03 | Upgrade
|
| Short-Term Investments | 21.86 | 26.77 | 78.79 | 84.13 | - | - | Upgrade
|
| Cash & Short-Term Investments | 43 | 53.08 | 105.83 | 129 | 187.8 | 72.03 | Upgrade
|
| Cash Growth | -52.36% | -49.85% | -17.96% | -31.31% | 160.71% | -6.13% | Upgrade
|
| Other Receivables | - | - | - | - | - | 0.14 | Upgrade
|
| Receivables | - | - | - | - | - | 0.14 | Upgrade
|
| Prepaid Expenses | 2.93 | 2.87 | 3.76 | 2.38 | 2.68 | 2.67 | Upgrade
|
| Other Current Assets | - | - | 0 | - | - | - | Upgrade
|
| Total Current Assets | 45.92 | 55.94 | 109.6 | 131.38 | 190.48 | 74.84 | Upgrade
|
| Property, Plant & Equipment | 12.86 | 13.23 | 14.66 | 16.07 | 0.24 | 0.14 | Upgrade
|
| Long-Term Investments | 20.91 | 20.97 | 17.63 | 5.62 | 1.63 | - | Upgrade
|
| Other Intangible Assets | 0.04 | 0.09 | 0.2 | 0.22 | 0.26 | 0.32 | Upgrade
|
| Other Long-Term Assets | 1.93 | 1.93 | 1.94 | 1.97 | 1.93 | 0.63 | Upgrade
|
| Total Assets | 81.65 | 92.17 | 144.03 | 155.27 | 194.54 | 75.93 | Upgrade
|
| Accounts Payable | 1.95 | 3.19 | 3.7 | 1.95 | 7.13 | 5.45 | Upgrade
|
| Accrued Expenses | 6 | 5.99 | 6.52 | 4.5 | 7.67 | 12.03 | Upgrade
|
| Current Portion of Leases | 1.36 | 1.34 | 1.25 | 0.53 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 2.21 | Upgrade
|
| Other Current Liabilities | - | 0 | - | - | - | 2.37 | Upgrade
|
| Total Current Liabilities | 9.31 | 10.52 | 11.47 | 6.99 | 14.8 | 22.06 | Upgrade
|
| Long-Term Leases | 13.07 | 13.42 | 14.76 | 16 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | - | 10.17 | Upgrade
|
| Other Long-Term Liabilities | 0 | - | 30 | - | - | 0.06 | Upgrade
|
| Total Liabilities | 22.38 | 23.94 | 56.23 | 22.99 | 14.8 | 32.29 | Upgrade
|
| Common Stock | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Additional Paid-In Capital | 373.79 | 372.49 | 365.59 | 357.77 | 351.03 | 337.76 | Upgrade
|
| Retained Earnings | -314.53 | -304.3 | -277.87 | -225.53 | -171.36 | -294.19 | Upgrade
|
| Comprehensive Income & Other | -0.05 | -0.04 | - | -0.04 | - | - | Upgrade
|
| Total Common Equity | 59.28 | 68.23 | 87.8 | 132.27 | 179.75 | 43.63 | Upgrade
|
| Shareholders' Equity | 59.28 | 68.23 | 87.8 | 132.27 | 179.75 | 43.63 | Upgrade
|
| Total Liabilities & Equity | 81.65 | 92.17 | 144.03 | 155.27 | 194.54 | 75.93 | Upgrade
|
| Total Debt | 14.43 | 14.76 | 16 | 16.54 | - | - | Upgrade
|
| Net Cash (Debt) | 28.57 | 38.32 | 89.83 | 112.47 | 187.8 | 72.03 | Upgrade
|
| Net Cash Growth | -61.69% | -57.34% | -20.13% | -40.11% | 160.71% | -6.13% | Upgrade
|
| Net Cash Per Share | 0.40 | 0.54 | 1.27 | 1.60 | 2.76 | 1.23 | Upgrade
|
| Filing Date Shares Outstanding | 71.11 | 71.08 | 70.71 | 70.49 | 70.37 | 65.75 | Upgrade
|
| Total Common Shares Outstanding | 71.11 | 71.01 | 70.69 | 70.47 | 70.36 | 65.74 | Upgrade
|
| Working Capital | 36.61 | 45.42 | 98.13 | 124.39 | 175.68 | 52.78 | Upgrade
|
| Book Value Per Share | 0.83 | 0.96 | 1.24 | 1.88 | 2.55 | 0.66 | Upgrade
|
| Tangible Book Value | 59.24 | 68.13 | 87.6 | 132.05 | 179.49 | 43.31 | Upgrade
|
| Tangible Book Value Per Share | 0.83 | 0.96 | 1.24 | 1.87 | 2.55 | 0.66 | Upgrade
|
| Machinery | 1.53 | 1.53 | 1.46 | 1.42 | 0.5 | 0.32 | Upgrade
|
| Leasehold Improvements | 0.31 | 0.31 | 0.31 | 0.31 | - | - | Upgrade
|
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.